Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02918123
Recruitment Status : Recruiting
First Posted : September 28, 2016
Last Update Posted : March 14, 2018
Sponsor:
Information provided by (Responsible Party):
Kang Stem Biotech Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021